BNET Industries
Last Fiscal Year Sales:$2.5B
- Public
- US
Dow Jones Description
This generic drug manufacturer is everything but. Barr Pharmaceuticals (NYSE: BRL), founded in 1970, has cemented a specific role in modern medicine-the production of generic drugs. The company has 75 different generic pharmaceuticals, and has been on the frontline of women's health, producing the Plan B emergency contraceptive and hormone therapy products. The company is based in Pomona, NY, has revenue of $1 billion 1,900 and employees. In December 2005 the company acquired FEI Women's Health and ParaGard IUD product.
Chief Executive Officer
Bruce L. DowneyNumber of Employees 2,040
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
Litigation Update from the Yaz, Yasmin and Ocella Lawyers at the Roberts Law Firm
-
Cephalon, Barr Settle Fentora Patent Suit
-
UPDATE 1-Cephalon, Barr settle patent infringement suit
-
My Two Healthcare Favorites
-
UPDATE 1-Watson, Barr settle patent dispute over Oxytrol
-
Albany Molecular files Allegra patent lawsuits
-
Acetylon Pharmaceuticals Raises $7.25 Million Series A to Develop Next-Generation Selective...
News & Analysis
Filter by
barr pharmaceuticals inc. and nyse euronext - All News and Analysis
Zacks Bull and Bear of the Day Highlights: Telus Corp., Overstock.com, Barr Pharmaceuticals, Actions Semiconductor and Sonic Innovations
CHICAGO -- Zacks Equity Research highlights Telus Corporation (NYSE: TU) as the Bull of the Day and Overstock.com, Inc. (Nasdaq: OSTK) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Barr Pharmaceuticals, Inc. (NYSE: BRL), Actions Semiconductor (Nasdaq: ACTS) and Sonic Innovations (Nasdaq: SNCI). ...
Breaking Market News! February 23, 2006.
M2 PRESSWIRE-23 February 2006-Wall Street News Alert: Breaking Market News! February 23, 2006C1994-2006 M2 COMMUNICATIONS LTD RDATE:23022006 Weston, FLA. - Wall Street News Alert's "stocks to watch" this Thursday morning are: ER Urgent Care Centers (OTC: ERUG), Nutrition 21, Inc., (NASDAQ:...
Leerink Swann & Company Initiates Coverage of Barr Pharmaceuticals, Inc. (NYSE: BRL) Mylan Laboratories Inc. (NYSE: MYL)
This morning, Senior Generic Pharmaceutical Analyst, William F. Sawyer, initiated coverage of Barr Pharmaceuticals (NYSE: BRL) with an Outperform rating and Mylan Laboratories Inc. (NYSE: MYL) with a Market Perform rating. He bases his investment rating for Barr on his view that solid operating performance from Barr's generic and branded...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Bruce L. Downey | Chief Executive Officer |
| Suzanne Donaghy | CIO & Vice President |
| William T. McKee | CFO, Vice President & Treasurer |
| Catherine Higgins | Senior Vice President, HR |
| Christine Mundkur | Senior Vice President, Quality & Regulatory Counsel |
| Frederick J. Killion | Senior Vice President |
| Michael Bogda | Senior Vice President, Manufacturing & Engineering |
| Salah Ahmed | Senior Vice President, Prod Development |
| Timothy Catlett | Senior Vice President, Sales & Marketing |
| Amy Nieman | Vice President, Marketing, Proprietary Prods |
| Carol Cox | Vice President, Investor Relations & Corp Communications |
| Christopher Mengler | Vice President, Strategic Planning |
| David J. Furniss | Vice President, Internal Audit |
| Jake Hansen | Vice President, Govt Affairs |
| Lance J. Bronnenkant | Vice President, Operations, Res & Development |
| Phil Gioia | Vice President, Sales, Proprietary Prods |
| Tim Sawyer | Vice President, Sales, Generic Prods |
| Amy Niemann | |
| Charles E DiLiberti | |
| Daryl LeSueur | |
| Emad M Alkhawam | |
| Frederick Wilkinson | |
| Howard I Hait | |
| Jay Bapna | |
| Joseph A Carrado | |
| Michael Moorshead | |
| Richard H Mileski | |
| Robert Williford | |
| Robinson Kemoni | Investigator |
| Rocco J Rositano | |
| Shannon Thyme Klinger | |
| Wayne S Mulcahy |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| George P. Stephan | Audit Committee Chairman |
| Harold N. Chefitz | Compensation Committee Chairman |
| Peter R. Seaver | Corporate Governance & Nominating Committee Chairman |
| Carole Maimon | Board of Directors |
| Carole S. Ben-Maimon | Board Director |
| George P. Stephen | Board of Directors |
| Honorable James S. Gilmore III | Board of Directors |
| Jack M. Kay | Board Director |
| Richard R. Frankovic | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Chief Executive Officer | Current |
| Barr Pharmaceuticals, Inc. | Chairman | Current |
| Barr Pharmaceuticals, Inc. | Board of Directors | Current |
| Momenta Pharmaceuticals, Inc. | Board of Directors | Current |
| Winston & Strawn LLP | Partner | Former |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | CIO & Vice President | Current |
| Information Technology Group, Inc. | Former |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | CFO, Vice President & Treasurer | Current |
| Barr Pharmaceuticals, Inc. | Board of Directors | Current |
| Deloitte Touche Tohmatsu | Vice President, Finance | Former |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Senior Vice President, HR | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Senior Vice President, Quality & Regulatory Counsel | Current |
| Organization | Position | Status |
|---|---|---|
| Pharmacy Access Partnership | Executive Vice President and General Counsel | Current |
| Barr Pharmaceuticals, Inc. | Senior Vice President | Current |
| Pharmacy Access Partnership | Senior Vice President and General Counsel | Former |
| Strawn & Co | Partner | Former |
| Winston & Strawn LLP | Capital Partner | Former |
| Strawn & Co | Counsel | Former |
| Barr Pharmaceuticals, Inc. | General Counsel | Former |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Senior Vice President, Manufacturing & Engineering | Current |
| Bpi, Inc. | Vice President, Human Resources | Former |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Senior Vice President, Prod Development | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Senior Vice President, Sales & Marketing | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Vice President, Marketing, Proprietary Prods | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Vice President, Investor Relations & Corp Communications | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Vice President, Strategic Planning | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Vice President, Internal Audit | Current |
| Ernst & Young | audit manager | Former |
| Organization | Position | Status |
|---|---|---|
| Pharmacy Access Partnership | Senior Vice President, Global Government Affairs | Current |
| Barr Pharmaceuticals, Inc. | Vice President, Govt Affairs | Current |
| The Seniors Coalition | Vice President for Government Affairs | Former |
| American Conservative Union | Leadership Positions | Former |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Vice President, Operations, Res & Development | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Vice President, Sales, Proprietary Prods | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Vice President, Sales, Generic Prods | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Current | |
| Quality Control Corporation | Associate Director | Former |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Current | |
| Columbia Laboratories, Inc. | Chief Executive Officer | Former |
| Columbia Laboratories, Inc. | President | Former |
| Watson Pharmaceuticals, Inc. | Chief Operating Officer | Former |
| Watson Pharmaceuticals, Inc. | Senior Vice President | Former |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Current | |
| Scirex Corporation | Senior Director of Biostatistics | Former |
| Zeneca | Manager of Biometrics, Pharmaceuticals Group | Former |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Current | |
| Novartis AG | Environmental Compliance Officer | Former |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Current | |
| Encorium Group, Inc. | Regulatory Positions | Former |
| Aventis Pharmaceuticals Inc | Regulatory Liaison, Cardiovascular and Thrombosis Products | Former |
| Aventis Pharmaceuticals Inc | Director | Former |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Current |
Robinson Kemoni is a Research Investigator at Barr Pharmaceuticals Inc, in New York. In his current position, he is involved in the research and development of affordable medicines for the Healthcare Industry. He has previously worked with the Essential Drugs Program in Kenya. Mr. Kemoni received a Diploma in Pharmacy from the Kenya Medical Training College, BS from New Jersey City University and MS from Long Island University. He is a registered pharmacist in Kenya and a member of the American Association of Pharmaceutical Scientists.
| Organization | Position | Status |
|---|---|---|
| American Association of Pharmaceutical Scientists | Member | Current |
| Barr Pharmaceuticals, Inc. | Investigator | Current |
| Mra-Africa | Board of Directors | Current |
| Long Island University | Ms | Former |
| New Jersey City University | Bs | Former |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Current | |
| Teva Pharmaceuticals North America | Senior Director, Scientific and Regulatory Affairs | Former |
| Merck Sharp & Dohme | Clinical Research and Clinical Development Positions | Former |
| Teva Pharmaceuticals USA | Clinical Research and Clinical Development Positions | Former |
| Organization | Position | Status |
|---|---|---|
| Pharmacy Access Partnership | Business Consultant | Current |
| Barr Pharmaceuticals, Inc. | Audit Committee Chairman | Current |
| Pharmacy Access Partnership | Board of Directors | Current |
| Stonington Group | Managing Director | Former |
| Sartorius Sports | business consultant | Former |
| Kollmorgen Corporation | Chairman | Former |
| Sartorius Sports | Director | Former |
| Kollmorgen Corporation | Director | Former |
| Barr Pharmaceuticals, Inc. | Board Director | Former |
| Organization | Position | Status |
|---|---|---|
| Pharmacy Access Partnership | Chairman of Notch Hill Advisors and President of Chefitz Healthcare Investments | Former |
| Nitric Bio, Inc. | Board of Directors | Current |
| Nethealth Systems Inc | Board Member | Current |
| Emergingmed.Com, Inc | Board Member | Current |
| Furman Selz | Senior Managing Director | Former |
| Boles Knop LLC | Partner | Former |
| Barr Pharmaceuticals, Inc. | Board of Directors | Former |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Corporate Governance & Nominating Committee Chairman | Current |
| Harvard School of Dental Medicine | Board of Directors | Current |
| Pharmacy Access Partnership | Board of Directors | Current |
| Fellows, Inc. | Board of Directors | Current |
| Barr Pharmaceuticals, Inc. | Board Director | Former |
| Duramed Pharmaceuticals, Inc. | Director | Former |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Board Director | Current |
| Teva Pharmaceuticals USA | Senior Vice President Science and Public Policy, North America | Former |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Board of Directors | Current |
| Cypress Communications | Board of Directors | Current |
| CACI International Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Board Director | Current |
| Organization | Position | Status |
|---|---|---|
| Barr Pharmaceuticals, Inc. | Board of Directors | Current |
| Pharmacy Access Partnership | Board of Directors | Current |
| Duramed Pharmaceuticals, Inc. | Board of Directors | Former |
Executive News
-
Acetylon Pharmaceuticals Raises $7.25 Million Series A to Develop Next-Generation Selective...
-
Acetylon Pharmaceuticals Raises $7.25 Million Series A to Develop Next-Generation Selective HDAC Inhibitors for Cancer and Rheumatoid Arthritis
-
Momenta Pharmaceuticals, Inc. Q2 2009 Earnings Call Transcript
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes



